Reagents and Antibodies

JBC Papers in Press. Published on August 28, 2002 as Manuscript M205386200

Proteomic Analysis of a Detergent-resistant Membrane Skeleton from Neutrophil Plasma Membranes

Thomas Nebl1, Kersi N. Pestonjamasp1,2, John D. Leszyk3, Jessica L. Crowley1, Sang W. Oh1, and Elizabeth J. Luna1,4

Department of Cell Biology, University of Massachusetts Medical School, 377 Plantation Street, Worcester, MA 01605.

2

Current address: Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037. 3

Proteomic Mass Spectrometry Laboratory, University of Massachusetts Medical School, Worcester Foundation Campus, 222 Maple Avenue, Shrewsbury, MA 01545

4

Corresponding Author: Elizabeth Luna Department of Cell Biology University of Massachusetts Medical School Biotech 4, Suite 306, 377 Plantation St. Worcester, MA 01605 Tel: 508-856-8661 Fax: 508-856-8774 [email protected] Running Title: DRM Membrane Skeletons

1

Copyright 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Downloaded from http://www.jbc.org/ by guest on July 23, 2016

1

Nebl et al.

DRM Membrane Skeletons

ABBREVIATIONS αH340, antibodies against the amino-terminal 340 amino acids of human supervillin; DRM, detergentresistant membrane fragments; DRM-H, DRMs with higher buoyant densities (1.15-1.18 g/ml); DRM-L, DRMs with lower buoyant densities (1.09-1.13 g/ml); EST, expressed sequence tag; GAPR-1, Golgi-associated plant pathogenesis-related protein 1; GPI, glycophosphatidylinositol; GST, glutathione S-transferase; H340, the aminoterminal 340 amino acids of human supervillin; HC, heavy chain; HBSS, Hank's deficient saline solution buffered with 10 mM HEPES, pH 7.4; HRP, horseradish peroxidase; MALDI-TOF, matrix assisted laser desorption/ionization time of flight: MS/MS, tandem mass spectrometry; MT-6-MMP, membrane-type 6 matrix metalloproteinase; OG, octylglucoside extraction buffer (0.1 M octylglucoside, 25 mM Tris, 250 mM NaCl, 2.5 mM MgCl2, 1 mM EGTA, 1 mM ATP); PSD, post-source-decay; SDS-PAGE, SDS-polyacrylamide gel electrophoresis; Triton extraction buffer (1% Triton X-100, 25 mM Tris, 250 mM NaCl, 2.5 mM MgCl2, 1 mM EGTA, 1 mM ATP); TFA, trifluoroacetic acid.

Key words: Membrane skeleton, neutrophil, lipid raft, TIFF, GEMs, DIGs

2


TBS, Tris-buffered saline (25 mM Tris-HCl, 1 mM EDTA, pH 7.4); TBST, TBS containing 0.05% Tween-20; TEB,

Nebl et al.


SUMMARY

Plasma membranes are organized into functional domains both by liquid-ordered packing into ‘lipid rafts’, structures that resist Triton extraction, and by attachments to underlying cytoskeletal proteins in assemblies called ‘membrane skeletons’. Although the actin cytoskeleton is implicated in many lipid raft-mediated signaling processes, little is known about the biochemical basis for actin involvement. We show here that a subset of plasma membrane skeleton proteins from bovine neutrophils co-isolates with cholesterol-rich, detergent-resistant membrane fragments (DRMs) that exhibit a relatively high buoyant density in sucrose (DRM-H; d ~ 1.16g/ml). Using MALDITOF and tandem mass spectrometry, we identified 19 major DRM-H proteins. Membrane skeleton proteins include

protein, supervillin. Other DRM-H components include lipid raft-associated integral membrane proteins (stomatin, flotillin 1, flotillin 2), extracellular surface-bound and GPI-anchored proteins (IgM, membrane-type 6 matrix metalloproteinase), and intracellular dually acylated signaling proteins (Lyn kinase, Gαi-2). Consistent with cytoskeletal association, most DRM-H associated flotillin 2, Lyn, and Gαi-2 also resist extraction with 0.1 M octylglucoside. Supervillin, myosin-IG, and myosin-IIA resist extraction with 0.1 M sodium carbonate, a treatment that removes all detectable actin, suggesting that these cytoskeletal proteins are proximal to the DRM-H bilayer. Binding of supervillin to the DRM-H fragments is confirmed by co-immunoaffinity purification. In spreading neutrophils, supervillin localizes with F-actin in cell extensions and in discrete basal punctae that partially overlap with Gαi staining. We suggest that the DRM-H fraction represents a membrane skeleton-associated subset of leukocyte signaling domains.

3


fodrin (nonerythroid spectrin), myosin-IIA, myosin-IG, α-actinin 1, α-actinin 4, vimentin, and the F-actin binding

Nebl et al.


INTRODUCTION Plasma membranes in eukaryotic cells are organized into domains of specialized function. Many of these domains are relatively stable on the cell surface and involve a series of linkages between cytoplasmic cytoskeletal proteins, integral membrane proteins, and extracellular attachments to the substrate or to other cells. For example, intermediate filament anchorages to membranes at desmosomes and hemidesmosomes distribute mechanical stresses over epithelial surfaces and maintain the integrity of skin and other tissues (1,2). Plasma membrane domains anchored to actin filaments include spectrin-based meshworks, adsorptive cell surface microvilli, focal adhesions and adherens junctions (3-7). In each of these domains, interactions between cytoskeletal proteins provide resistance against disruption by nonionic detergents, such as Triton X-100 and octylglucoside, permitting the transmembrane

Lipid-lipid interactions also can organize membranes into detergent-resistant domains. Such lipid “rafts” are stabilized against disruption by cold Triton X-100 through liquid-ordered packing of component cholesterol, (glyco)sphingolipids, and gel-phase glycerolipids (9,10). Lipid rafts contain resident integral membrane proteins, such as caveolin, stomatin, and flotillin (11), extracellular proteins with glycophosphatidylinositol (GPI)-anchors containing long-chain fatty acids (12), and cytoplasmic proteins modified by a dual myristoylation/palmitoylation motif or by palmitoylation on two or more cysteine residues (13-15). When analyzed in vivo by spectroscopic methods, plasma membrane lipid rafts consist of clusters of ~20 proteins and ~3500 sphingolipid molecules and are ~50 nm in diameter, a size well below the resolution limit of light microscopy (16,17). These dimensions can be increased into the submicron to micron range through aggregation of raft components, e.g., by receptor activation or addition of bivalent antibodies against raft-associated surface antigens (18-20). After treatment of cells or membranes with cold Triton X-100, the coalescing detergent-resistant remnants of the lipid rafts are called detergentresistant membranes (DRMs). DRMs, which represent a subset of the endogenous raft lipids and proteins (21), can be recovered by flotation into low-density fractions (DRM-L) from sucrose or Optiprep™ gradients (19).

Both cytoskeleton-stabilized membrane domains and lipid rafts provide sites at which localized signal transduction can occur (3,8,19). Selective recruitment of proteins from the cytoplasm or protein diffusion within the

4


protein assembly to be isolated as a “membrane skeleton” (8).

Nebl et al.


plane of the membrane can regulate signaling events, such as those downstream of growth factor addition, ion channel activation, or changes in cell adhesion. Because many signaling proteins--including heterotrimeric Gα proteins and members of the Src family of protein tyrosine kinases--are dually acylated, lipid rafts have been proposed as platforms for the controlled interaction of substrates and signaling enzymes (19,22). Lipid rafts also have been proposed to play roles in membrane targeting and endocytotic trafficking (23). Cascades of recruitment of adaptor proteins and kinases to lipid rafts are well characterized during receptor activation in B lymphocytes, T lymphocytes, and mast cells (19). Compartmentalized signaling at lipid rafts may be especially important for hematopoietic cells, which form dynamic attachments to substrates and other cells and lack many types of stable cell surface adhesions. Although signaling downstream of lipid raft-associated adhesive stimuli requires filamentous

F-actin is known to be an important structural and functional component of plasma membranes from mammalian neutrophils (26). Neutrophils are the most abundant of the circulating leukocytes and are readily available in large quantities from bovine blood (27-29). They are terminally differentiated granulocytes that constitute the body's first line of defense against invading microbes (30). In response to chemotactic stimuli from pathogens or from other immune cells and/or mucosal cells, neutrophils rapidly migrate across capillary endothelia into body tissues (31). They engulf microbes coated with complement proteins and/or immunoglobulins and kill the ingested microorganisms by releasing proteases, antimicrobial proteins, and oxygen metabolites into phagolysosomal compartments. Although polarity is maintained by cytoplasmic microtubules (32), actin function in the membrane skeleton and/or cortical cytoskeleton is required for chemotactic signaling, cell movement, adhesion, and phagocytosis (33).

Despite its importance in early immune defense, the neutrophil membrane skeleton is largely uncharacterized. In agreement with previous observations of a spectrin-, actin-, and band 4.1-containing membrane skeleton in neutrophils (34,35), we have shown that a macromolecular complex containing fodrin (non-erythrocyte spectrin), actin, and nonmuscle myosin-IIA exists in bovine neutrophil plasma membranes (28,36). We also have used F-actin blot overlays and immunoblotting to show that neutrophil plasma membranes contain ezrin, moesin, and a 205-kDa F-actin binding protein that we named supervillin. Molecular cloning of supervillin cDNA indicated that

5


actin (24,25), the role of F-actin in this process is unknown.

Nebl et al.


this protein contains a C-terminus with predicted similarities to villin and a novel N-terminus (36,37). The supervillin N-terminus contains functional nuclear targeting signals, sites for direct binding to F-actin, and regions that promote actin filament binding and bundling (38). Supervillin is a tightly bound peripheral membrane protein that is concentrated at sites of epithelial cell-cell adhesion (36). This protein also has been reported to be a minor constituent of lipid rafts from detergent-solubilized Jurkat T cells (39) and to co-purify with P2X7 ATP receptors from embryonic kidney cells (40). Supervillin message levels are elevated in neutrophils stimulated with lipopolysaccharide from gingivitis-causing bacteria (41), implying a role during physiological activation of neutrophils.


6

Nebl et al.


EXPERIMENTAL PROCEDURES

Reagents and Antibodies The protease inhibitors, 4-(2-aminoethyl)benzenesulfonyl fluoride, leupeptin and bestatin, were purchased from Calbiochem-Novabiochem Corp. (San Diego, CA). Density gradient centrifugation media, Percoll™ and Optiprep™, were from Amersham Pharmacia Biotech AB (Piscataway, NJ) and Nycomed Pharma AS (Oslo, NOR), respectively. Tosyl-activated or protein A-conjugated Dynabeads M-280 were from Dynal Inc. (Lake Success, NY). Nonspecific control rabbit IgG and mouse monoclonal primary antibodies against α-actinin, β-actin and vimentin

from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Monoclonal anti-flotillin 2 was from BD Transduction Laboratories/ BD PharMingen (San Diego, CA), monoclonal anti-α-fodrin was from ICN Biomedicals Inc. (Aurora, OH) and polyclonal rabbit anti-nonmuscle myosin-II IgG was from Biomedical Technologies Inc. (Stoughton, MA).

Myosin-IG was stained by a monoclonal antibody raised against chicken brush-border myosin (myosin-IA) that recognizes the head domain of multiple myosin-I isoforms (42,43) and also by affinity-purified rabbit IgG against a consensus myosin-IA peptide (G-371) (44). These antibodies were the kind gifts of Dr. Mark Mooseker (Yale University, New Haven, CT), and Dr. Martin Bähler (Westfälische Wilhelms-Universität Münster, GER), respectively. Horseradish peroxidase (HRP)-conjugated sheep IgG against bovine IgM was from Serotech Ltd. (Oxford, GBR). HRP-conjugated, as well as alkaline phosphatase-conjugated, goat anti-rabbit IgG and goat anti– mouse IgG were purchased from Jackson ImmunoResearch Laboratories Inc. (West Grove, PA). AlexaFluor 488 goat F(ab’)2 anti-rabbit IgG and AlexaFluor 568 goat F(ab’)2 anti-mouse IgG were purchased from Molecular Probes Inc. (Eugene, OR). All other chemicals were purchased from Sigma-Aldrich Corp.

Affinity-purified Anti-supervillin IgG The HSV41 clone (37) containing human supervillin cDNA sequences (Accession #AF051851) was digested with EcoRI and NotI and ligated into the pGEMEX-1 vector (Promega Corp., Madison, WI). A chimeric

7


were purchased from Sigma-Aldrich Corp. (St. Louis, MO). Monoclonal anti-Lyn and anti-Gαi-2 antibodies were

Nebl et al.


fusion protein consisting of 260 amino acids of T7 gene10 and linker sequence plus the first 340 amino acids of human supervillin (H340) was expressed in BL21(DE3) bacteria after induction with isopropyl β-Dthiogalactopyranoside. The fusion protein was purified as inclusion bodies and used as an immunogen for the production of rabbit polyclonal antisera (Research Genetics, Huntsville, AL). Antibodies against the amino-terminal 340 amino acids of human supervillin (αH340) were affinity purified against a chimeric fusion protein of H340 and glutathione S-transferase (GST). The GST-H340 protein was expressed in bacteria from sequences encoded by the pGEX-6P-1 vector and HSV41 cDNA and was purified on glutathione-Sepharose™, as described by the manufacturer (Amersham Pharmacia Biotech). All manipulations were carried out at 4ºC, unless stated otherwise. Purified GST-H340 (~12 mg) was dialyzed against 20 mM sodium phosphate buffer (pH 7.6) and coupled to ~1.5 ml

ester (pH 8.0) for 24 h, washed with 40 ml of sodium phosphate buffer (pH 7.6), 2 ml of 4.5 M MgCl2, 10 ml TBS (25 mM Tris-HCl, 1 mM EDTA, pH 7.4), and stored in TBS containing 0.1% thimerosal. The GST-H340 Sepharose beads were rotated overnight with 10-ml aliquots of specific rabbit antisera and washed sequentially at room temperature with: (1) ~150 ml TBS, (2) 6 ml 1 M NaCl in TBS, (3) 4 ml 2 M urea in TBS, and (4) 2 ml 10 mM Tris-HCl (pH 7.5). High-affinity antibodies were eluted with 4.5 M MgCl2, 72.5 mM Tris (pH 7.0) and collected in 1-ml fractions with equivalent volumes of 10 mM Tris-HCl (pH 7.5). Fractions containing affinitypurified IgG were pooled, repeatedly diluted with 10 mM Tris-HCl (pH 7.5), and re-concentrated to ~0.3 ml by centrifugation at 2000 x g using Ultra-Free-10™ ultrafiltrate concentrators (Millipore Corp., Bedford, MA). Concentrated antibody was clarified by centrifugation at 13,000 x g for 5 min and stored in aliquots at –20 °C with ~1 mg/ml BSA and 50% (v/v) sterile glycerol. The specificity of αH340 antibody was confirmed by immunoblots of whole neutrophil extracts (Fig. 1A), and the suitability for staining of paraformaldehyde-fixed samples was demonstrated using immunolabeling experiments with COS-7 cells expressing a GFP-tagged bovine supervillin (not shown). H340 antigen was purified by cleavage from GST-H340 and chromatography on glutathione™-Sepharose and DEAE-Sepharose, as recommended by the manufacturer (Amersham Pharmacia Biotech).

8


CNBr-activated Sepharose 6MB (Sigma-Aldrich Corp.) for 24 h. The column was blocked with 0.2 M glycine ethyl

Nebl et al.


Neutrophil Isolation Polymorphonuclear leukocytes were routinely isolated from 8 -10 liters of bovine blood provided by Research 87 Inc. (Marlborough, MA). Peripheral blood was collected from a single animal, immediately mixed 9:1 (v/v) with anti-coagulant solution (3.8% (w/v) sodium citrate, 2.5 mM EDTA, 50,000 units heparin) and stored on ice overnight. Neutrophils (~ 95% pure) were obtained by hypoosmotic lysis of erythrocytes, followed by fractionation on preformed gradients of isotonic Percoll™ (27,28,45). Cells were washed twice and resuspended in Hank’s deficient saline solution buffered with 10 mM HEPES, pH 7.4 (HBSS). All manipulations were carried out at 4ºC.

Neutrophils were treated with 5 mM DFP for 15 min, washed and resuspended in relaxation buffer (28) (10 mM PIPES, 100 mM KCl, 3 mM NaCl, 3.5 mM MgCl2, 1 mM ATP, 1 mM EGTA, pH 7.3) containing a mix of protease inhibitors (1 mM PMSF, 0.4 µM aprotinin, 10 µM E-64, 20 µM leupeptin, 10 µM bestatin, 5 µM N-acetylLeu-Leu-Met-al, 2 µM pepstatin), and disrupted by nitrogen cavitation. All manipulations were carried out at 0-4ºC. Cavitates were centrifuged at 1000 x g for 10 min to remove nuclei, and 10-ml aliquots of postnuclear supernatant were loaded onto 28 ml of 1.06 g/ml Percoll™ suspension in relaxation buffer. Initially, plasma membranes were separated from secretory vesicles, granules, and cytosol using Percoll™ step gradients, as described previously (28,36). As a faster alternative to manual pipetting, Percoll™ density gradients were generated by centrifugation. Density gradients were generated by centrifugation at 50,000 x g for 30 min in a Beckman VTi50 vertical rotor. Neutrophil plasma membranes corresponded to the "γ fraction" (~1.04 g/ml) from these gradients. This fraction was enriched ~10-fold in cell surface (28) and plasma membrane (27,45) markers. After centrifugation at 140,000 x g for 2 h to remove residual Percoll™ particles, plasma membranes were resuspended in relaxation buffer containing protease inhibitors, disrupted with 10 to 20 strokes of a tight-fitting Teflon dounce homogenizer and stored in aliquots at –80ºC.

9


Neutrophil Plasma Membranes

Nebl et al.


Immunofluorescence Microscopy Neutrophils suspended in HBSS were seeded onto coverslips that were coated with poly-L-lysine or Zymosan-activated plasma (ZAP) for 15 min at 22ºC (28). ZAP was prepared by incubating bovine plasma (from the same batch of peripheral blood used to isolate the neutrophils) with 5 mg/ml Zymosan at 37°C for 60 min and clarified by centrifugation at 100,000 x g for 60 min. Non-adherent cells were removed, and adherent unactivated (poly-L-lysine) or activated (ZAP) cells were incubated at 37ºC in 5% C02 for 30 - 60 min in 10 mM potassium phosphate, 130 mM NaCl, 0.6 mM CaCl2, 1 mM MgCl2, 2.7 mM KCl, 0.18 % glucose, pH 7.4. Neutrophils were fixed with 4% paraformaldehyde in PBS (pH 7.4) for 10 min, washed three times in PBS and then permeabilized using 0.5% Triton X-100 for 10 min at 22ºC. Exposed cytoplasmic surfaces of neutrophil plasma membranes were

6.9 (28,46), delivered from a syringe with a 26 gauge needle at an oblique angle across the surface of the coverslip. Sheared cells were immediately fixed in 2% paraformaldehyde in the same buffer for ~15 min at 22ºC. Fixed samples were washed 3 x 5 min in PBS and blocked at 4ºC overnight, or for up to 3 days, with 10% bovine serum, 0.02% sodium azide, 0.02% thimerosal in PBS (pH 7.4). Samples then were incubated 2 - 4 h with 3 µg/ml affinitypurified αH340 or non-specific rabbit IgG alone, or together with mouse monoclonal anti-Gαi-2 antibody at 2 µg/ml in blocking solution. As an additional specificity control, aliquots of affinity-purified αH340 were incubated for 2 h with 10 µg/ml purified H340 antigen before addition to coverslips. After three washes in PBS, samples were incubated with blocking solution containing 2 µg/ml AlexaFluor 488-labelled F(ab’)2 fragment of goat anti-rabbit IgG and either 2 µg/ml AlexaFluor 568-labelled F(ab’)2 fragment of goat anti-mouse IgG or 50 nM rhodamine phalloidin. At these antibody concentrations, no significant background was observed in the absence of primary antibody (not shown). After final washes, samples were mounted with VectaShield™ mounting medium (Vector Laboratories Inc., Burlingame, CA) and observed using an MC100 Axioskop epifluorescence microscope with filters for Texas Red and fluorescein (Carl Zeiss Inc., Thornwood, NY). Phase contrast and fluorescence micrographs were acquired with a Model Retiga-1300 QImaging Camera and processed using Openlab imaging software (Improvision Inc., Lexington, MA). Confocal immunofluorescence images were recorded on a Bio-Rad MRC 1024 laser scanning confocal microscope equipped with a krypton/argon laser and LaserSharp Version 3.2 software (Bio-Rad

10


obtained by disrupting cells with a focussed jet of 60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl2, pH

Nebl et al.


Laboratories, Hercules, CA). No bleed-through fluorescence between different channels was detected in doublelabel experiments.

Detergent-resistant Membranes Detergent-resistant membranes were prepared as shown (Fig. 2A, 3A). Pelleted neutrophil plasma membranes (Fig. 3A, #1) were resuspended to 1-2 mg of membrane protein per ml of Triton X-100 extraction buffer (TEB: 1% Triton X-100, 25 mM Tris, 250 mM NaCl, 2.5 mM MgCl2, 1 mM EGTA, 1 mM ATP) containing protease inhibitors and were incubated for 60 min on ice. Samples (6 x 2.7 ml) were underlayered with 0.3 ml 48% (v/v) Optiprep™ in TEB and centrifuged at 100,000 x g for 60 min at 4ºC in a Beckman TLA 100.3 rotor.

Triton X-100 extracted plasma membranes (Fig. 3A, #2), was collected and adjusted to 30% (v/v) with TEB and/or 60% Optiprep™. Centrifugation of aliquots (8 x 500 µl) at 350,000 x g for 2 h at 4ºC in a Beckman TLA120.1 rotor generated gradients of Optiprep™ with detergent-resistant membrane fragments (DRMs) floating at low buoyant density (Fig. 2A). Fractions (50 µl) were collected and analyzed for total protein concentration using BCA assay reagent (Pierce, Rockford, IL), for total cholesterol concentration using Infinity cholesterol assay reagent (SigmaAldrich Corp.), and for refractive indices using a model 334610 refractometer (Bausch & Lomb, Rochester, NY), according to manufacturer’s instructions. Cholesterol-rich DRM fractions were then pooled (total DRMs; Fig. 3A, #4), mixed with an equal volume of TEB and centrifuged into linear 20 – 45% (w/v) sucrose density gradients at 200,000 x g for 18 h at 4°C in a Beckman SW50.1 rotor. Single gradients were fractionated (300 µl) at a rate of 0.5 ml/min using a Model 640 density gradient fractionator (Isco Inc., Lincoln, NE). Aliquots were assayed for total protein and density and analyzed by SDS-PAGE, silver staining, and Western blotting, as described in the figure legends. Fractions containing lighter (DRM-L, d~1.09 – 1.13 g/ml; Fig. 3A, #5) and denser (DRM-H, d ~1.15 – 1.18 g/ml; Fig. 3A, #6) DRMs were identified, pooled and stored at –80°C until use.

Electron Microscopy Transmission electron microscopy of plasma membrane thin-sections was carried out as detailed earlier (36). Negative staining of the DRM-H fraction was performed according to published methods (47), with minor

11


Supernatant was discarded. The sharp opalescent band at the top of the Optiprep™ cushion, which represented the

Nebl et al.


modifications. Briefly, DRM-H fractions were deposited onto EM grids that had been coated with carbon and glowdischarged on the day of the experiment. Samples were allowed to adhere for 30-60 s, stained for 30 s with 2% OsO4 in 0.1 M cacodylate buffer (pH 7.4) and for 30 s with 2% uranyl acetate in PBS (pH 7.4). After each treatment, grids were rinsed with 6-10 drops of PBS and drained using filter paper. Stained samples were air-dried and examined on a model EM-301 transmission electron microscope (Philips Electron Optics Inc., Mahway, NJ) at an accelerating voltage of 60 kV.

Octylglucoside and Sodium Carbonate Extractions DRM-H preparations (600 µg) were diluted 1:1 with relaxation buffer and pelleted by ultracentrifugation

or 0.1 M octylglucoside extraction buffer (OG), or 0.1 M Na2CO3 and extracted for 60 min on ice. As a positive control, the pellet was completely solubilized by incubation in 200 µl 1% SDS at 70°C for 15 min. Samples were then re-centrifuged as above using a Beckman TLA120.1 rotor, and the pellets were resuspended to 200 µl with TEB. Both supernatants (S) and resuspended pellets (P) were adjusted to final concentrations of 1% Triton X-100, 250 mM NaCl, 50 mM Tris-HCl, pH 7.5. Volumes equivalent to 100 µl of the initial assay mixture were analyzed by SDS-PAGE, silver staining, and Western blotting.

Gel Electrophoresis and Immunoblotting Protein or volume equivalents of Optiprep™/sucrose density gradient fractions or DRM-H isolates/extracts were separated at 4°C on high-resolution 100 x 140 x 1.5 mm 5–15% gradient polyacrylamide SDS-gels (48). Coomassie Blue and silver staining were performed according to standard protocols (49). Molecular mass standards were prestained full range Rainbow markers (Amersham Pharmacia Biotech). Separated proteins were documented by digitally scanning gels using a model GS-700 imaging densitometer (Bio-Rad Laboratories, Hercules, CA). For immunoblotting, gels were electrotransferred to nitrocellulose membranes (Schleicher & Schuell, Keene, NH) at 4°C. Blots were (1) blocked with 5% (w/v) nonfat dry milk in TBST (TBS containing 0.05% Tween-20) for 60 min, (2) incubated with the appropriate antibody for 2 – 4 h in this blocking solution, (3) washed 3 x 5 min in TBST, (4) incubated for 1 – 2 h with alkaline phosphatase- or HRP-conjugated goat anti-rabbit or anti-mouse IgG in blocking

12


(100,000 x g, 60 min, 4°C) using a Beckman TLA120.2 rotor. Pellets (100 µg) were resuspended in 200 µl of TEB,

Nebl et al.


solution, (5) washed 3 x 5 min in TBST, and (6) visualized with BCIP/NBT Membrane Phosphatase Substrate (Kirkegaard & Perry Laboratories, Gaithersburg, MD) or Renaissance™ Western Blot Chemiluminescence Reagent Plus (NEN Life Science Products Inc., Boston, MA), as appropriate. Results were quantified after exposure to BIOMAX MR Scientific Imaging Film (Eastman Kodak Company, Rochester, NY) and/or digitally scanned, as above.

MALDI-TOF and MS/MS via MALDI Post Source Decay For identification of DRM-H associated proteins, protein bands were excised from Coomassie blue-stained gels with clean razor blades. Gel pieces (~ 1.5 x 1.5 x 6 mm) were rinsed 3 x 5 min in deionized water. In-gel

0.01% n-octylglucopyranoside in the digest buffer. Peptide digests were concentrated using ZipTip C18 micropipette tips (Millipore Corp.) according to recommended protocols, with the exception that the ion-pairing agent trifluoroacetic acid (TFA) was replaced by 1% formic acid. MALDI-TOF and Post-Source-Decay (PSD) data were obtained on an AXIMA-CFR mass spectrometer using software version 2.0.1 (Kratos Analytical, Manchester, UK). Typically, mass spectrometric spectra were obtained at a laser power near threshold with pulsed extraction optimized for 2,000 Da; mass resolutions varied from 6,000 to 9,000 across the tryptic peptide mass range. PSD data were obtained at a laser power ~15% higher than threshold. Samples were co-crystallized with α-cyano-4hydroxycinnamic acid (10 mg/ml in 1% formic acid, 50% acetonitrile) via the dried drop method. External calibration in MS mode was accomplished by a 3 point peptide mixture which covered the mass range typical of tryptic digests (600-2,500Da), and spotted locally to the sample of interest. PSD fragment ions were fitted to a generated curve, which was calibrated with PSD fragments from the synthetic peptide, P14R. Database searches were performed using Protein Prospector version 3.4.1 (http://prospector.ucsf.edu). Monoisotopic peptide masses were searched against the NCBI nonredundant database using the MS-Fit program and 50-100 ppm mass tolerances. PSD fragments were searched against the NCBI nonredundant database using MS-Tag and 0.2 Da as the parent tolerance and 0.5 Da as the fragment ion tolerance.

13


tryptic digests were performed according to published protocols (50) with minor modifications, e.g., the addition of

Nebl et al.


Immunoaffinity Purification Preparative immunoisolations of supervillin DRM complexes were performed as previously described (36) and confirmed by analytical-scale experiments, using M280 tosyl-activated or protein-A conjugated Dynabeads. Affinity-purified rabbit αH340 IgG and non-specific control rabbit IgG (0.5 mg aliquots) in PBS (pH 7.5) were coupled to washed Dynabeads by end-over-end rotation overnight at 37°C (tosyl-activated) or 4ºC (protein Aconjugated). Protein A-bound IgG was crosslinked using 20 mM dimethylpimelimidate in 0.2 M sodium borate (pH 8.5) for 45 min at room temperature. Unreacted sites on protein beads were blocked in 0.2 M glycine ethyl ester (pH 8.2) overnight at 4ºC. Crosslinked antibody beads were washed 3 x 10 min in borate buffer (pH 8.2), 1 x 10 min in 0.1 M sodium acetate (pH 4.5) and 3 x 10 min in TEB (pH 7.4). In analytical experiments, aliquots of neutrophil

X100 or 0.1 M octylglucoside. The resulting detergent extracts were incubated for an additional 4 h at 4°C with Dynabeads (~5 x 107 beads/tube) containing covalently bound supervillin-specific αH340 or non-specific rabbit IgG plus 1% BSA (for silver staining) or 5% goat serum (for immunoblot analyses). Unbound material, including BSA and goat serum proteins, was removed by washing the beads 3 x 10 min in extraction buffer with 1% Triton-X100 or 0.1 M octylglucoside, respectively. Immunoadsorbed material was magnetically separated, eluted in SDS sample buffer at 70ºC for 10 min and analyzed by SDS-PAGE, silver staining, and immunoblotting.

14


plasma membranes (250 µg protein) were incubated for 1 h at 4ºC in 0.5 ml extraction buffer containing 1% Triton-

Nebl et al.


RESULTS

Neutrophil Membrane Actin and Supervillin Using the αH340 antibody specific for supervillin (Fig. 1A), supervillin was co-localized with actin filaments at the peripheries of adherent neutrophils (Fig. 1B, e-h). Most unactivated neutrophils appeared round and roughly symmetrical, with evenly-distributed cortical F-actin and supervillin (not shown). Activated neutrophils exhibited a spread, polarized morphology with supervillin and F-actin accumulations in ruffles and membrane protrusions (Fig. 1B, a-h). To examine signals from proteins closely associated with the plasma membrane, the ventral membrane skeleton was exposed by mechanical shear of spreading neutrophils (51,52). Membrane sheets

(Fig. 1B, m-p). These punctae were concentrated at or near the leading edges of lamellipodial extensions and occasionally were observed along radially projecting actin bundles. Staining also appeared as small patches within the interiors of the adherent membranes. No patches or punctae were observed with nonspecific rabbit IgG (Fig. 1B, b) or after preadsorption of the αH340 antibody with antigen (Fig. 1B, j), indicating specificity. These results suggest that supervillin is associated with a subset of the F-actin rich neutrophil membrane skeleton that appears as discrete membrane-associated domains.

Supervillin-associated DRMs We previously showed that Triton-insoluble remnants of the neutrophil plasma membrane contained F-actin and the actin-binding membrane skeleton proteins, fodrin, myosin-IIA, and supervillin (53). Resistance to solubilization by Triton X-100 suggested an association with the underlying cytoskeleton, but also was consistent with an association with DRMs. We now report that, after Triton extraction of neutrophil plasma membranes, these membrane skeleton proteins exhibit low densities in Optiprep™ gradients and partition into fractions containing elevated ratios of cholesterol to protein (Fig. 2A, 2B). These fractions also are enriched in proteins immunoreactive with antibodies against Gαi-2 and Lyn kinase (Fig. 2C). All three of these properties are hallmarks of DRMs (10,16,54). The presence of at least two distinguishable membrane bands at the tops of the gradients (Fig. 2A, arrows) suggested heterogeneity, such as that reported for DRMs isolated from lung (55,56), smooth muscle (57),

15


representing the cytoplasmic faces of basal membranes contained discrete actin- and supervillin-associated punctae

Nebl et al.


and tissue culture cells (39,58).

Further purification of this light membrane fraction (Fig. 3A, #4) from Optiprep™ gradients by sedimentation into linear 20-45% sucrose density gradients demonstrated that neutrophil plasma membrane DRMs contain both lower buoyant density (DRM-L; Fig. 3A, #5) and higher buoyant density (DRM-H; Fig. 3A, #6) DRMs. DRM-L fractions exhibited densities of ~1.09 to 1.13 g/ml, values similar to those reported for DRMs containing GPI-anchored proteins, heterotrimeric G-proteins, and Src family kinases (13,14,59). DRM-H fractions exhibited densities of 1.15 to 1.18 g/ml (Fig. 3A) and were highly enriched in polypeptides with the mobilities of fodrin and actin (Fig. 3B, arrowheads), membrane skeleton proteins reported to associate with DRMs (55,60,61). These and

10- to 20-fold purification of DRM-H from total Triton-insoluble neutrophil plasma membranes (Fig. 3B). Conversely, the DRM-H fraction was depleted of numerous low molecular mass membrane proteins (Fig. 3B, lane 3), as well as of most glycosylated proteins recognized by the lectin, concanavalin A (data not shown).

As visualized by negative stain electron microscopy, the DRM-H fraction contained both membrane sheets and filamentous material (Fig. 3D). Cytoskeletal filaments reminiscent of those associated with neutrophil plasma membranes (Fig. 3D, panel a) also were apparent in micrographs of the DRM-H fraction (Fig. 3D, panel b). These filaments were associated with membrane fragments with surface areas of 0.05-0.5µm2 that also contained a semiregular array of particles with diameters of ~25 nm (Fig. 3D, panel c). Thus, the DRM-H fraction consisted of detergent-resistant membrane microdomains tightly associated with a discrete set of membrane skeleton proteins.

Abundant DRM-H Proteins We used a mass spectrometric approach to identify 25 polypeptides in the 23 DRM-H bands that stained most intensely with Coomassie blue (Fig. 4). These polypeptides were representative of 19 proteins or protein complexes, many of which are characteristic of liquid-ordered microdomains. For instance, the DRM-H proteins, stomatin, flotillin 1 and flotillin 2, are oligomeric integral membrane proteins found in lipid rafts from erythrocytes, brain, lung, and numerous other tissues (62-64). The DRM-H fraction also contained the Golgi-associated plant pathogenesis-related protein GAPR-1 (65), the dually-acylated non-receptor tyrosine kinase Lyn, subunits of the

16


other polypeptides were consistently enriched (see below), along with supervillin (Fig. 3C), during the approximately

Nebl et al.


heterotrimeric Gi-2 protein, and the GPI-anchored membrane-type 6 matrix metalloproteinase (MT-6-MMP, MMP25, leukolysin). These membrane proteins are targeted to liquid-ordered microdomains through covalent modifications with saturated fatty acyl groups (12-14,17,59).

Membrane skeleton proteins constituted a second major category of proteins in the DRM-H fraction. We found heterodimeric fodrin (nonerythrocyte spectrins αII and βII), β-actin, and other F-actin binding proteins, including supervillin, α-actinin 1, α-actinin 4, nonmuscle myosin-IIA heavy and light chains, and the heavy chain and calmodulin light chain of myosin-IG, an unconventional myosin originally identified as a minor histocompatibility antigen (66,67). The DRM-H fraction also contained the intermediate filament protein, vimentin,

and light chains may be attached extracellularly through a specific Fc receptor, which is reported to exist on bovine neutrophils (70-72). Other proteins, such as clathrin, bactenecin (a positively-charged neutrophil defensin), and the G18.1b polypeptide (which is known only as ESTs and a predicted open reading frame) are less easily categorized.

To confirm that these proteins were in the same structure as supervillin, a tightly-bound neutrophil membrane skeleton protein (36), we immunoisolated supervillin-containing lipoprotein complexes from unfractionated detergent extracts of neutrophil plasma membranes (Fig. 5). Of the many proteins present in the total Triton X-100 extract of plasma membranes (Fig. 5A, lane a), a specific subset of at least 15 silver-stained polypeptides (Fig. 5A, lane d, arrowheads and dashes) was recovered with beads coated with an affinity-purified IgG specific for supervillin (Fig. 5A, lane b). These 15 polypeptides were not observed in experiments with non-specific rabbit IgG (Fig. 5A, lane c), indicating specificity. The overall pattern and molecular masses of these polypeptides (Fig. 5A, arrowheads and dashes) were very similar to the SDS-gel profile and sizes of cytoskeletal and signaling proteins identified by mass spectrometric analysis (Fig. 4A). The identities of eight of these major silver-stained polypeptides were confirmed by immunoblotting (Fig. 5B), using antibodies specific for α-fodrin, non-muscle myosin-II, supervillin, Lyn kinase, flotillin 2, β-actin, Gαi-2, and myosin-I head domains. All eight proteins were specifically adsorbed to Dynabeads coated with anti-supervillin IgG (Fig. 5B, αH340), as compared with control rabbit IgG (Fig. 5B, control). The other ten polypeptides identified in Figure 4 also may be present in the anti-

17


which binds fodrin (68) and which has been reported in other liquid-ordered microdomains (69). The IgM heavy

Nebl et al.


supervillin pellets but could not be assayed by immunoblot analyses due to antibody unavailability, co-migration with IgG, and/or low molecular mass. Interestingly, similar results were obtained with both 1% Triton X-100, which does not extract lipid raft proteins (Fig. 5B, TEB), and with 100 mM octylglucoside (Fig. 5B, OG), which does (58, 73). Thus, most or all of the proteins identified as components of the DRM-H fraction are associated in the same lipoprotein complexes as supervillin, and these complexes may contain differentially stabilized lipid raft components.

Relative Extractabilities To test the relative strengths of association between DRM-H proteins and lipids, we extracted the DRM-H

pellets were analyzed for the presence of component proteins (Fig. 6). We then organized the resulting immunoblots (Fig. 6, middle columns) from least extractable, i.e., most tightly bound (Fig. 6, top), to most extractable, i.e., most weakly bound (Fig. 6, bottom). Sedimentation of proteins in 1% Triton-extraction buffer (TEB; Fig. 6, left column), or following membrane solubilization in hot 1% SDS (SDS; Fig. 6, right column) served as negative and positive controls, respectively. With octylglucoside (Fig. 6, OG), we observed partial solubilization of Lyn and IgM, but relatively little dissociation of the raft proteins, flotillin 2 and Gαi-2. In extractions with sodium carbonate (Fig. 6, Na2CO3), the integral (flotillin 2) and lipid-anchored (Gαi-2, Lyn) membrane proteins were retained in the pellets, as expected. Extractabilities of the membrane skeleton proteins varied from completely extracted (actin, α-actinin) and ~50% extracted (fodrin) to only ~20-25% extracted (myosin-IIA, myosin-IG) and virtually unextracted (supervillin). Because a significant portion of supervillin can be extracted with 1 M KCl and 0.1 N NaOH, pH 13 (36), we conclude that it is a peripheral membrane protein that is very tightly associated with DRM-H lipids and/or integral membrane proteins. Surprisingly, myosin-IIA and myosin-IG are also relatively tightly associated with these membranes, remaining bound even after the removal of all detectable actin.

DRM-H is a Subset of Neutrophil Lipid Domains Sucrose density gradient profiles showed that DRM-H was characterized by increased amounts of membrane skeleton proteins, whereas most signaling proteins exhibited a biphasic distribution between DRM-L and

18


fraction with 0.1 M octylglucoside or 0.1 M sodium carbonate, pH 11.5. Supernatants and extracted membrane

Nebl et al.


DRM-H (Fig. 7A, 7B). As assessed from immunoblot analyses of equal protein loads, all of the assayed proteins coisolated to some degree with both DRM-L and DRM-H (Fig. 7B). The major difference between DRM-L and DRMH was the higher percentages of fodrin, supervillin, myosin-IG, and actin that were associated with DRM-H fractions. DRM-H also contained significant amounts of myosin-IIA, Lyn kinase, the lipid raft marker flotillin 2 and Gαi-2 immunoreactive proteins. Thus, after Triton extraction of neutrophil plasma membranes, there is both considerable overlap between the compositions of DRM-L and DRM-H and a characteristic enrichment of cytoskeletal proteins in association with DRM-H membranes. Increased association of cytoskeletal proteins correlates with increased sedimentability in sucrose density gradients (Fig. 7C).

proteins (Fig. 7B), we observed partial but significant overlap between the supervillin and Gαi immunofluorescent signals in adherent membrane fragments from lysed neutrophils (Fig. 7D). This co-localization was especially prominent in punctae at the F-actin rich membrane peripheries of actively spreading cells (Fig. 7D, a – c). By contrast, only occasional overlap of supervillin and Gαi signals was observed in the centers of the membrane remnants (Fig. 7D, d – f). The extent of co-localization observed by immunofluorescence microscopy (Fig. 7D) was roughly consistent with the degree to which supervillin and Gαi-2 immunoreactive proteins co-purified in the DRM-H sucrose density fractions (Fig. 7B). Taken together with the identification of Gαi-2 as a major co-purifying protein (Fig. 4), these observations suggest that supervillin both co-localizes and co-purifies with a subset of Gαi-2 associated signaling domains. These results further suggest that the isolated DRM-L and DRM-H fractions represent different lateral domains within the neutrophil plasma membrane.

19


In agreement with the observation of overlapping and distinct biochemical pools of supervillin and Gαi

Nebl et al.


DISCUSSION

In this paper, we present proteomic and microscopic evidence for a DRM-associated membrane skeleton from neutrophil plasma membranes (Fig. 1-7). This lipoprotein complex is enriched in cholesterol (Fig. 2) and exhibits a higher buoyant density than do DRMs with less associated membrane skeleton material (Fig. 3, 7, DRM-H vs. DRM-L). Cytoskeletal proteins characteristically enriched in this fraction include fodrin, supervillin, myosin-IIA, myosin-IG, and α-actinins 1 and 4 (Fig. 3-7). Immunoaffinity purification of supervillin-associated DRM complexes confirms that these proteins are in the same lipoprotein complexes (Fig. 5). Octylglucoside extraction demonstrates that most of the hydrophobically associated lipid raft proteins in this complex are relatively stabilized against

supervillin, myosin-IIA, and myosin-IG, are very tightly associated with DRM lipids and/or integral membrane proteins, remaining bound even in the absence of detectable actin (Fig. 6). As supervillin and Gαi-2 immunoreactive proteins appear to preferentially co-localize in actin-rich areas of cells engaged in active spreading (Fig. 1, 7D), the DRM-H fraction may represent a transiently-induced, membrane skeleton-associated subset of neutrophil signaling domains (Fig. 8).

The buoyant density of the DRM-H fraction (d ~1.16 g/ml) is probably the reason it has not been described previously. DRM purification methods typically involve the collection of lipoprotein complexes with densities within the range of 1.02 to 1.16 (5% - 35% sucrose) (39,74), whereas Triton-insoluble membrane skeletons characteristically exhibit densities of 1.25 – 1.3 (~50% - 64% sucrose) (75,76). Presumably, attachment of DRMassociated proteins to the cytoskeleton causes an increased density due to the increased ratio of protein to lipid in the detergent-resistant fraction, resulting in equilibrium banding at intermediate sucrose concentrations. DRMs with densities in the range of our DRM-H fraction (d ~ 1.15 – 1.18; 33% - 40% sucrose) are likely to sediment, or to be spread throughout, the 30 – 35% sucrose step gradient used in many DRM purification methods (39,74). Similarly, the DRM-H fraction would not be detected in related lipoprotein complexes prepared in the absence of nonionic detergents (58,77,78) because these complexes are isolated after carbonate extraction and/or sonication, procedures that remove most associated cytoskeletal proteins (e.g., Fig. 6).

20


extraction by this detergent (Fig. 5-6). Carbonate extraction demonstrates that the peripheral membrane proteins,

Nebl et al.


Although DRMs are commonly assumed to reflect the compositions and morphologies of lipid domains in vivo, these isolated structures may differ in detail from their endogenous counterparts (54,58,79). Also, the isolated DRM-H fraction is not necessarily homogeneous with respect to the relative ratios of the co-isolating proteins. For instance, the small amount of DRM-H clathrin (Fig. 4) may be caused by a few contaminating coated pits, or it may represent a limited association between coated membrane and a subset of DRMs. Other components of the DRM-H fraction, especially proteins present in minor amounts, remain for future analysis. The determination of which proteins interact through direct interactions and which are co-associated through a common affinity for the gel-phase DRM lipids is similarly beyond the scope of this investigation. However, the silver-stained profile of proteins that

antibodies directed against supervillin (Fig. 5). This result suggests that supervillin directly or indirectly associates with lipoprotein complexes containing the other proteins in Figure 4 and may therefore serve as a marker protein for DRM-H rafts in neutrophil plasma membranes.

Our results are consistent with electron microscopic observations of a subplasmalemmal filament complex associated with Triton X-100-extracted neutrophil ghosts (80) and plasma membrane remnants of sheared neutrophils (51,52). In the latter studies, high-resolution scanning electron micrographs revealed that the cytoplasmic surfaces of adherent, spreading neutrophils contain interlocking networks of globular centers and radiating branched filaments. Morphologically similar networks are observed in cross-sections of purified plasma membranes (Fig. 3D, panel a) and in negatively stained DRM-H samples (Fig. 3D, panel b, c). Given our observations of myosin-IIA and myosin-IG bound to DRMs lacking detectable F-actin, these domains may represent regions at which actin and myosin are recruited and organized at the membrane, as originally implied (52).

Our data also agree with the initial observation that neutrophils contain a fodrin- and actin-based, detergentresistant membrane skeleton (35). This membrane skeleton has been implicated in the lateral organization of components of the superoxide-generating machinery (81) and in the segregation of chemoreceptors and Gi-2 proteins during neutrophil stimulation (34,82,83,84,85). The partial superimposition of the supervillin and Gαi-2

21


co-sediment as the DRM-H fraction (Fig. 3, 4, 7) is similar to the pattern of proteins that are co-purified using

Nebl et al.


immunofluorescence signals (Fig. 7D) suggests that at least some of these areas of overlap may correspond to domains involved in the active signaling between chemotactic receptors and the actin cytoskeleton.

Actin, spectrin or fodrin, and/or associated proteins have been co-purified with lipid raft components from other hematopoietic cell types. For example, erythrocyte DRMs are enriched in stomatin, flotillins 1 and 2, β-actin, and a loosely bound member of the spectrin gene family (65). More recently, a complex mixture of DRMs from unstimulated Jurkat T lymphocytes was found to contain a subset of proteins reminiscent of those identified here (39). Among a total of ~70 DRM proteins–including markers for mitochondria, rough endoplasmic reticulum, the Golgi complex, and the nuclear envelope–were sequences representative of fodrin, myosin-IIA heavy and light

tyrosine kinase Lck. Although it is not known whether these proteins co-associate with each other in T cells, as opposed to being present in different DRMs, it is striking that twelve of the twenty-five polypeptides identified in our study are also present in total Jurkat T cell DRMs. Thus, lipid raft-associated membrane skeletons similar to DRMH may be present in hematopoietic cells of different origin.

The neutrophil DRM-H fraction also exhibits some compositional similarities to the microdomains associated with the multichain receptor for IgE (FcεR) in mast cells (86,87). Both types of domains are cholesterolrich and contain bound immunoglobulin, actin, and Lyn kinase (19,88). The relatively tight association of IgM with DRM-H fragments (Fig. 6) is consistent with the reported presence of a specific receptor for IgM on bovine neutrophils (70-72). In mouse and human, a ~70-kDa receptor that binds IgA as well as IgM (Fcα/µR) has been shown to mediate internalization of IgM-coated Staphylococcus aureus (89). Another Fcµ receptor exists as a ~60kDa GPI-linked isoform in hematopoietic cells (90,91). Either type of Fcµ receptor would be hard to detect in the presence of the more abundant, co-electrophoresing IgM decamer, leaving open the question of whether the IgM that co-sediments with the neutrophil DRM-H fraction is bound through a specific Fc receptor.

Although not previously documented, the actin-independent association of myosins and other F-actin binding proteins with DRMs is consistent with reports indicating that lipid raft domains are intrinsically linked to

22


chains, supervillin, myosin-IG (GenBank EST AI089291), vimentin, β-actin, flotillin 2, Gαi-2 and the Src-related

Nebl et al.


active movements of the cortical actin cytoskeleton (92,93). After priming by receptor occupancy with IgE, for example, the FcεR is associated with Lyn in lipid rafts on mast cells (86). Following receptor crosslinking by multivalent antigen, the structure and organization of these microdomains are changed both by actin-based lateral movements of signal transduction proteins within the plane of the membrane and by recruitment of signaling proteins from cytoplasmic stores (94,95). Similar mechanisms also target specific lipid raft components to the front and rear of polarized leukocytes (24,25,96) and to the immunological synapses of stimulated T-cells (93,97).

We hypothesize that fodrin, myosin-IIA, myosin-IG, and supervillin are components of a mobile, actinbased membrane skeleton that regulates the organization and/or transport of cholesterol-rich signaling domains at the

stabilize and/or localize these domains within the membrane. While the intracellular localization of myosin-IG is unknown, fodrin and myosin-II both localize throughout the cortex, as well as at the plasma membrane (98,99). By contrast, plasma membrane-associated supervillin is observed as punctae or patches in many cell types (36,38), suggesting that supervillin may be a characteristic component of this type of lipid raft-associated membrane skeleton. The tight association between supervillin and DRM-H fragments, in conjunction with supervillin’s highaffinity binding for F-actin and its ability to reorganize cytoskeletal structures (36,38), suggests that supervillin may be involved in recruitment of the actin-based cytoskeleton to such liquid-ordered regions of the plasma membrane. The tight association of myosin motors with the DRM-H fragments suggests the possibility of a role in membrane transport or directed motility at the cell surface.

23


neutrophil plasma membrane (Fig. 8). Associations with membrane skeleton components also could differentially

Nebl et al.


ACKNOWLEDGMENTS The authors gratefully acknowledge Dr. Gregory Hendricks for assistance with the electron microscopy, Drs. Mark Mooseker and Martin Bähler for their generous gifts of antibodies against myosin I sequences, and Dr. Silvia Corvera for providing anti-clathrin heavy chain antibody. We also thank Megan Staples for help with immunoaffinity purification, Louise Ohrn for the megaliters of solutions used for plasma membrane purification, and Ernestina Bernal and Donna Castellanos for expert glassware washing. This publication was made possible by grant number GM33048 from the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Downloaded from http://www.jbc.org/ by guest on July 23, 2016

24

Nebl et al.


BIBLIOGRAPHY 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13.

25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41.

25


14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24.

Jonkman, M. F. (1999) J Dermatol Sci 20, 103-121 McMillan, J. R., and Shimizu, H. (2001) J Dermatol 28, 291-298 Bennett, V., and Baines, A. J. (2001) Physiol Rev 81, 1353-1392 Bloch, R. J., Bezakova, G., Ursitti, J. A., Zhou, D., and Pumplin, D. W. (1997) Soc Gen Physiol Ser 52, 177-195 Geiger, B., and Bershadsky, A. (2001) Curr Opin Cell Biol 13, 584-592 Lange, K. (2002) Am J Physiol Cell Physiol 282, C1-26 Nagafuchi, A. (2001) Curr Opin Cell Biol 13, 600-603 Luna, E. J., and Hitt, A. L. (1992) Science 258, 955-964 London, E., and Brown, D. A. (2000) Biochim Biophys Acta 1508, 182-195 Rietveld, A., and Simons, K. (1998) Biochim Biophys Acta 1376, 467-479 Galbiati, F., Razani, B., and Lisanti, M. P. (2001) Cell 106, 403-411 Benting, J., Rietveld, A., Ansorge, I., and Simons, K. (1999) FEBS Lett 462, 47-50 Melkonian, K. A., Ostermeyer, A. G., Chen, J. Z., Roth, M. G., and Brown, D. A. (1999) J Biol Chem 274, 3910-3917 Moffett, S., Brown, D. A., and Linder, M. E. (2000) J Biol Chem 275, 2191-2198 Zacharias, D. A., Violin, J. D., Newton, A. C., and Tsien, R. Y. (2002) Science 296, 913-916 Pralle, A., Keller, P., Florin, E. L., Simons, K., and Horber, J. K. (2000) J Cell Biol 148, 997-1008 Varma, R., and Mayor, S. (1998) Nature 394, 798-801 Friedrichson, T., and Kurzchalia, T. V. (1998) Nature 394, 802-805 Simons, K., and Toomre, D. (2000) Nat Rev Mol Cell Biol 1, 31-39 Thomas, J. L., Holowka, D., Baird, B., and Webb, W. W. (1994) J Cell Biol 125, 795-802 Pike, L. J., Han, X., Chung, K. N., and Gross, R. W. (2002) Biochemistry 41, 2075-2088 Bickel, P. E. (2002) Am J Physiol Endocrinol Metab 282, E1-E10. Mukherjee, S., and Maxfield, F. R. (2000) Traffic 1, 203-211 Gomez-Mouton, C., Abad, J. L., Mira, E., Lacalle, R. A., Gallardo, E., Jimenez-Baranda, S., Illa, I., Bernad, A., Manes, S., and Martinez, A. C. (2001) Proc Natl Acad Sci USA 98, 9642-9647. Seveau, S., Eddy, R. J., Maxfield, F. R., and Pierini, L. M. (2001) Mol Biol Cell 12, 3550-3562. Stossel, T. P. (1994) Sci Am 271, 54-55, 58-63 Mottola, C., Gennaro, R., Marzullo, A., and Romeo, D. (1980) Eur J Biochem 111, 341-346. Pestonjamasp, K., Amieva, M. R., Strassel, C. P., Nauseef, W. M., Furthmayr, H., and Luna, E. J. (1995) Mol. Biol. Cell 6, 247-259 Salgar, S. K., Paape, M. J., and Alston-Mills, B. (1994) Am. J. Vet. Res. 55, 803-809 Stossel, T. P., and Babior, B. M. (1995) in Blood: Principles and Practice of Hematology (Handin, R. I., Stossel, T. P., and Lux, S. E., eds), pp. 575-619, J.B. Lippincott Company, Philadelphia, PA Godaly, G., Bergsten, G., Hang, L., Fischer, H., Frendeus, B., Lundstedt, A. C., Samuelsson, M., Samuelsson, P., and Svanborg, C. (2001) J Leukoc Biol 69, 899-906 Nabi, I. R. (1999) J Cell Sci 112, 1803-1811 Jones, G. E. (2000) J Leukoc Biol 68, 593-602 Jesaitis, A. J., Bokoch, G. M., Tolley, J. O., and Allen, R. A. (1988) J. Cell Biol. 107, 921-928 Stevenson, K. B., Clark, R. A., and Nauseef, W. M. (1989) Blood 74, 2136-2143 Pestonjamasp, K. N., Pope, R. K., Wulfkuhle, J. D., and Luna, E. J. (1997) J Cell Biol 139, 1255-1269 Pope, R. K., Pestonjamasp, K. N., Smith, K. P., Wulfkuhle, J. D., Strassel, C. P., Lawrence, J. B., and Luna, E. J. (1998) Genomics 52, 342-351 Wulfkuhle, J. D., Donina, I. E., Stark, N. H., Pope, R. K., Pestonjamasp, K. N., Niswonger, M. L., and Luna, E. J. (1999) J Cell Sci 112, 2125-2136 von Haller, P. D., Donohoe, S., Goodlett, D. R., Aebersold, R., and Watts, J. D. (2001) Proteomics 1, 10101021 Kim, M., Jiang, L. H., Wilson, H. L., North, R. A., and Surprenant, A. (2001) EMBO J 20, 6347-6358 Morozumi, T., Kubota, T., Sugita, N., Ohsawa, Y., Yamazaki, K., and Yoshie, H. (2001) J Periodontal Res 36, 160-168.

Nebl et al.

42. 43. 44. 45. 46. 47. 48. 49. 50. 51. 52. 53.

56. 57. 58. 59. 60. 61. 62. 63. 64. 65. 66. 67. 68. 69. 70. 71. 72. 73. 74. 75. 76. 77.

Carboni, J. M., Howe, C. L., West, A. B., Barwick, K. W., Mooseker, M. S., and Morrow, J. S. (1987) Am J Pathol 129, 589-600 Peterson, M. D., and Mooseker, M. S. (1992) J Cell Sci 102, 581-600 Ruppert, C., Godel, J., Muller, R. T., Kroschewski, R., Reinhard, J., and Bähler, M. (1995) J Cell Sci 108, 3775-3786 Del Buono, B. J., Luscinskas, F. W., and Simons, E. R. (1989) J. Cell. Physiol. 141, 636-644 Hartwig, J. H., Chambers, K. A., and Stossel, T. P. (1989) J. Cell Biol. 108, 467-479 Bremer, A., Häner, M., and Aebi, U. (1998) in Cell Biology: A Laboratory Handbook (Celis, J., ed) Vol. 3, second edition, pp. 277-284. Academic Press, Boston Laemmli, U. K. (1970) Nature (Lond) 227, 680-685 Dell'Angelica, E., and Bonifacino, J. (2000) in Current Protocols in Cell Biology (Bonifacino, J., Dasso, M., Harford, J., Lippincott-Schwartz, J., and Yamada, K., eds) Vol. 1, pp. 6.6.1-6.6.2, 2 vols. John Wiley & Sons, New York Gharahdaghi, F., Weinberg, C. R., Meagher, D. A., Imai, B. S., and Mische, S. M. (1999) Electrophoresis 20, 601-605 Boyles, J., and Bainton, D. F. (1979) J. Cell Biol. 82, 347-368 Boyles, J., and Bainton, D. F. (1981) Cell 24, 905-914 Luna, E. J., Pestonjamasp, K. N., Cheney, R. E., Strassel, C. P., Lu, T. H., Chia, C. P., Hitt, A. L., Fechheimer, M., Furthmayr, H., and Mooseker, M. S. (1997) Soc Gen Physiol Ser 52, 3-18 Brown, D. A., and London, E. (1998) Annu Rev Cell Dev Biol 14, 111-136 Lisanti, M. P., Scherer, P. E., Vidugiriene, J., Tang, Z., Hermanowski-Vosatka, A., Tu, Y.-H., Cook, R. F., and Sargiacomo, M. (1994) J. Cell Biol. 126, 111-126 Schnitzer, J. E., McIntosh, D. P., Dvorak, A. M., Liu, J., and Oh, P. (1995) Science 269, 1435-1439 Chang, W.-J., Ying, Y., Rothberg, K. G., Hooper, N. M., Turner, A. J., Gambliel, H. A., De Gunzburg, J., Mumby, S. M., Gilman, A. G., and Anderson, R. G. W. (1994) J. Cell Biol. 126, 127-138 Smart, E. J., Ying, Y.-S., Mineo, C., and Anderson, R. G. W. (1995) Proc Natl Acad Sci USA 92, 1010410108 Oh, P., and Schnitzer, J. E. (2001) Mol Biol Cell 12, 685-698 Nelson, W. J., and Hammerton, R. W. (1989) J Cell Biol 108, 893-902 Fujimoto, T., Nakade, S., Miyawaki, A., Mikoshiba, K., and Ogawa, K. (1992) J. Cell Biol 119, 1507-1513 Bickel, P. E., Scherer, P. E., Schnitzer, J. E., Oh, P., Lisanti, M. P., and Lodish, H. F. (1997) J Biol Chem 272, 13793-13802. Eberle, H. B., Serrano, R. L., Fullekrug, J., Schlosser, A., Lehmann, W. D., Lottspeich, F., Kaloyanova, D., Wieland, F. T., and Helms, J. B. (2002) J Cell Sci 115, 827-838 Schulte, T., Paschke, K. A., Laessing, U., Lottspeich, F., and Stuermer, C. A. (1997) Development 124, 577-587 Salzer, U., and Prohaska, R. (2001) Blood 97, 1141-1143. den Haan, J. M., Sherman, N. E., Blokland, E., Huczko, E., Koning, F., Drijfhout, J. W., Skipper, J., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., and et al. (1995) Science 268, 1476-1480. Pierce, R. A., Field, E. D., Mutis, T., Golovina, T. N., Von Kap-Herr, C., Wilke, M., Pool, J., Shabanowitz, J., Pettenati, M. J., Eisenlohr, L. C., Hunt, D. F., Goulmy, E., and Engelhard, V. H. (2001) J Immunol 167, 3223-3230 Langley, R. C., Jr., and Cohen, C. M. (1987) Cell Motil Cytoskeleton 8, 165-173 Runembert, I., Queffeulou, G., Federici, P., Vrtovsnik, F., Colucci-Guyon, E., Babinet, C., Briand, P., Trugnan, G., Friedlander, G., and Terzi, F. (2002) J Cell Sci 115, 713-724 Grewal, A. S., Rouse, B. T., and Babiuk, L. A. (1978) Int Arch Allergy Appl Immunol 56, 289-300 Williams, M. R., and Hill, A. W. (1982) Res Vet Sci 33, 47-53 Worku, M., Paape, M. J., Filep, R., and Miller, R. H. (1994) Am J Vet Res 55, 221-226 Melkonian, K. A., Chu, T., Tortorella, L. B., and Brown, D. A. (1995) Biochemistry 34, 16161-16170 Fiedler, K., Kobayashi, T., Kurzchalia, T. V., and Simons, K. (1993) Biochemistry 32, 6365-6373 Goodloe-Holland, C. M., and Luna, E. J. (1987) Meth Cell Biol 28, 103-128 Sheetz, M. P. (1979) Biochim Biophys Acta 557, 122-134 Song, K. S., Li, S., Okamoto, T., Quilliam, L. A., Sargiacomo, M., and Lisanti, M. P. (1996) J Biol Chem 271, 9690-9697

26


54. 55.


Nebl et al.

78. 79. 80. 81. 82. 83. 84. 85. 86. 87. 88. 89.

94. 95. 96. 97. 98. 99. 100. 101. 102.

Waugh, M. G., Lawson, D., and Hsuan, J. J. (1999) Biochem J 337, 591-597 Dobrowsky, R. T. (2000) Cell Signal 12, 81-90 Jesaitis, A. J., Naemura, J. R., Sklar, L. A., Cochrane, C. G., and Painter, R. G. (1984) J Cell Biol 98, 13781387 Quinn, M. T., Parkos, C. A., and Jesaitis, A. J. (1989) Biochim Biophys Acta 987, 83-94 Jesaitis, A. J., Tolley, J. O., Bokoch, G. M., and Allen, R. A. (1989) J Cell Biol 109, 2783-2790 Klotz, K.-N., and Jesaitis, A. J. (1994) BioEssays 16, 193-198 Sarndahl, E., Bokoch, G. M., Boulay, F., Stendahl, O., and Andersson, T. (1996) J Biol Chem 271, 1526715271 Sengelov, H., Boulay, F., Kjeldsen, L., and Borregaard, N. (1994) Biochem J 299, 473-479 Field, K. A., Holowka, D., and Baird, B. (1995) Proc Natl Acad Sci USA 92, 9201-9205 Holowka, D., and Baird, B. (2001) Semin Immunol 13, 99-105 Dykstra, M., Cherukuri, A., and Pierce, S. K. (2001) J Leukoc Biol 70, 699-707 Shibuya, A., Sakamoto, N., Shimizu, Y., Shibuya, K., Osawa, M., Hiroyama, T., Eyre, H. J., Sutherland, G. R., Endo, Y., Fujita, T., Miyabayashi, T., Sakano, S., Tsuji, T., Nakayama, E., Phillips, J. H., Lanier, L. L., and Nakauchi, H. (2000) Nat Immunol 1, 441-446 Nakamura, T., Kubagawa, H., Ohno, T., and Cooper, M. D. (1993) J Immunol 151, 6933-6941 Ohno, T., Kubagawa, H., Sanders, S. K., and Cooper, M. D. (1990) J Exp Med 172, 1165-1175 Rodgers, W., and Zavzavadjian, J. (2001) Exp Cell Res 267, 173-183 Valensin, S., Paccani, S. R., Ulivieri, C., Mercati, D., Pacini, S., Patrussi, L., Hirst, T., Lupetti, P., and Baldari, C. T. (2002) Eur J Immunol 32, 435-446 Wilson, B. S., Pfeiffer, J. R., and Oliver, J. M. (2000) J Cell Biol 149, 1131-1142 Holowka, D., Sheets, E. D., and Baird, B. (2000) J Cell Sci 113, 1009-1019 Manes, S., Mira, E., Gomez-Mouton, C., Lacalle, R. A., Keller, P., Labrador, J. P., and Martinez, A. C. (1999) EMBO J 18, 6211-6220. Villalba, M., Bi, K., Rodriguez, F., Tanaka, Y., Schoenberger, S., and Altman, A. (2001) J Cell Biol 155, 331-338 Fujimoto, T., and Ogawa, K. (1990) J Cell Sci 96, 477-484 Valerius, N. H., Stendahl, O., Hartwig, J. H., and Stossel, T. P. (1981) Cell 24, 195-202 Byers, T. J., and Branton, D. (1985) Proc Natl Acad Sci USA 82, 6153-6157 Feinstein, A., and Munn, E. A. (1969) Nature 224, 1307-1309 Pappin, D. J. (1997) Methods Mol Biol 64, 165-173

27


90. 91. 92. 93.


Nebl et al.


FIGURE LEGENDS

Figure 1: Supervillin and F-actin localizations in intact neutrophils and membrane sheets. A. Specificity of affinity-purified rabbit polyclonal IgG against supervillin (αH340). Immunoblot of whole bovine neutrophil lysate (100 µg) probed with αH340 and HRP-conjugated anti-rabbit secondary antibody. B. Phase (a, e, i, m) and immunofluorescence (b-d, f-h, j-l, n-p) images of intact neutrophils (a-h) and the cytoplasmic surfaces of basal plasma membrane remnants exposed by mechanical shearing of adherent neutrophils (i-p). Cells and membrane sheets were stained with rhodamine-phalloidin (F-actin) and Alexa488-labeled goat F(ab’)2 (antibody) against non-specific rabbit IgG (control), or affinity-purified αH340 IgG against supervillin (αH340), or

actin rich membrane extensions in polarized leukocytes (e-h) and as discrete ~200 nm patches in association with Factin rich lamellae in ventral membrane skeletons exposed by mechanical shear (m-p). Merged images (d, h, i, p) show antibody stain in green, F-actin in red, and overlap as yellow. Scale bars = 2 µm.

Figure 2: Supervillin co-purifies with cholesterol-rich DRMs A. Centrifuge tube containing detergent-resistant plasma membrane (DRM) fragments in buoyant density (d = 1.10 – 1.18 g/ml) fractions near the top of a 15-50% self-formed Optiprep gradient. Graphical depiction of this gradient, which contains membrane fractions #3 and #4, is shown in Fig. 3A. B. Cholesterol/protein ratios in fractions from similar self-forming Optiprep gradients (bar graph). Values represent the mean ± the standard deviation of five independent experiments. The density profile (-•-) of these gradients is sigmoidal, with regions of low (d < ~1.18 g/ml) and high (d > ~1.20 g/ml) buoyant densities separated by fractions of intermediate density. Most membrane protein (--▲--) remains at the bottom of the gradient (fractions 8-10). C. Immunoblots of samples (50 µg protein/ lane) probed with antibodies against Gαi-2, Lyn kinase, or affinity purified αH340 IgG (supervillin).

28


αH340 IgG that had been pre-incubated with 10 µg/ml H340 antigen (pre-adsorbed). Supervillin localizes within F-

Nebl et al.


Figure 3: Overview of neutrophil DRM-H isolation A. Flow chart illustrating the DRM-H isolation procedure, as detailed in Experimental Procedures. Fraction numbers correspond to the lane numbers in panels B and C. Silver stain (B) and immunostaining for supervillin (C) of aliquots (50 µg protein/lane) of purified neutrophil plasma membranes (lane 1); Triton-insoluble plasma membrane fraction (lane 2); dense fraction from Optiprep gradient (lane 3); light fraction from Optiprep gradient, i.e., total DRM fraction (lane 4); low-buoyant density (DRM-L) sucrose gradient fraction (lane 5); and high buoyant density (DRM-H) sucrose gradient fraction (lane 6). Percentage values of total protein represent the mean +/- standard deviation from five independent experiments. Arrowheads denote the migration positions of fodrin (top) and actin (bottom). D. Thin section (panel a) and negatively stained (panels b, c) electron micrographs of

pH conditions used to spread erythrocyte membrane skeletons (100), we observed 0.1- to 0.5-µm membrane sheets decorated with a semi-regular array of particles with diameters of ~ 25 nm, or about the diameter of an IgM pentamer (101). Bars, ~ 60 nm.

Figure 4: Identification of the major DRM-H polypeptides A. Coomassie blue-stained polypeptides in the DRM-H fraction (50 µg), with sizes of molecular mass markers in kDa on the left and band numbers of excised bands on the right. B. Abbreviations: #, band number; Mr (kDa), theoretical molecular mass of major polypeptides based on deduced amino acid sequences; Identity, based on MALDI-TOF and tandem mass spectrometry (MS/MS); MALDI-TOF, number of matching fragments/total fragments; Score, MOWSE score (102); PSD, peptides confirmed by MS/MS via post source decay; Accession #, SwissProt/PIR/Genbank accession numbers; WB, Western blot; Raft, lipid-raft associated protein; Surface, extracellular cell surface-bound protein; Cytoskeleton, cytoskeletal protein; nd, not determined. Superscripts: †, details in Supplementary Data; 1, non-erythrocyte spectrin αII/βII (fodrin) dimer/tetramer; 1*, ~150 kDa α-fodrin proteolytic degradation fragment; 2, non-muscle myosin-IIA heavy chain and regulatory light chain; 3, myosin-IG heavy and calmodulin regulatory light chain; 4, IgM heavy and light chain decamer; 5, heterotrimeric Gi-2 protein α and β subunits.

29


neutrophil plasma membranes (panel a) and DRM-H samples at pH 7.4 (panel b) and pH 5.5 (panel c). At the low

Nebl et al.


Figure 5: Co-immunopurification of DRM-H proteins with supervillin A. Silver stain of 100 µg neutrophil plasma membranes (lane a); Western blot of same sample probed with affinity-purified anti-supervillin rabbit IgG (lane b); Silver stain showing proteins co-eluting after preparative affinity purification with non-specific (lane c) or anti-supervillin rabbit IgG (lane d). Positions of polypeptides confirmed by immunoblotting (arrowheads) and their numbers designated in Figure 4 are shown. Lines indicate the positions of additional bands with molecular masses similar to those of DRM-H polypeptides identified by mass spectrometry. Asterisks denote the positions of rabbit IgG heavy and light chains. B. Immunoblots identifying DRM-H proteins that co-purify with supervillin during adsorption of lipoprotein complexes to paramagnetic beads

adsorptions were performed in the presence of 1% Triton X–100 extraction buffer (TEB) or extraction buffer with 100 mM octylglucoside (OG). Resuspended pellets were loaded for constant volume (80 µl/lane).

Figure 6: Association of membrane skeleton and signaling proteins with DRM-H membranes Purified DRM-H membrane fragments (Fig. 3, membrane fraction #6) were extracted with Triton-extraction buffer (TEB; negative control), 100 mM octylglucoside in extraction buffer (OG), 0.1 M sodium carbonate, pH 11.5 (Na2C03), or 1% hot SDS (SDS; positive control). Soluble (S) and insoluble (P) proteins were isolated at 150,000 x g for 60 minute. Volumes representing 100 µl of the initial extraction solutions were separated by SDS-PAGE. Immunoblot strips were probed using antibody against membrane skeleton and signaling proteins, as indicated. Most signaling proteins, myosins, and supervillin remained insoluble, even under conditions (OG) that solubilize DRM proteins not stabilized by association with cytoskeletal proteins (73). Actin, α-actinin and most of the fodrin were extracted by sodium carbonate, which removes loosely-bound peripheral membrane proteins.

30


coated with non-specific IgG (control) or with supervillin-specific αH340 antibody (αH340). These analytical-scale

Nebl et al.


Figure 7: DRM-H represents a membrane skeleton-associated subset of leukocyte signaling domains A. Silver-stained fractions (25 µg/lane) after centrifugation of neutrophil plasma membrane DRMs into a linear 20-45% sucrose density gradient.

This gradient contains opalescence visualized as DRM-L and DRM-H

(membrane fractions #5 and #6, in Fig. 3A). Arrows show positions of the proteins visualized by immunoblot analyses. B. Immunoblot analyses of sucrose density gradient fractions. Fractions (25 µg/ lane) from the gradient shown in A were blotted and probed with antibody against membrane skeleton (fodrin, supervillin, myosin-IG, actin, myosin-IIA), coated pit (clathrin), or lipid raft proteins (Lyn, flotillin 2, Gαi-2). Fodrin, supervillin, myosin-IG, and actin peak together in high-buoyant density sucrose gradient fractions (DRM-H). The heavy chains of myosin-IIA and clathrin were enriched in fractions of intermediate density. Lyn, flotillin 2 and Gαi-2 show a biphasic

density gradient fractions from top (1) to bottom (16). Approximate locations are shown for the gradient load (L), low-density DRMs (DRM-L), coated pits (CP), high density DRMs (DRM-H), and pellet (P). C. Densities (--l--) and apparent protein concentrations (--▲--) of the sucrose gradient fractions shown in A. D. Confocal immunofluorescence images show partial co-localization of supervillin and Gαi in peripheral micropatches of unroofed neutrophils. Neutrophils spread on poly-L-lysine coated coverslips were mechanically sheared and stained with Alexa488- and Alexa568-labeled goat secondary antibodies against rabbit polyclonal anti-supervillin IgG and mouse monoclonal anti-Gαi-2 IgG, respectively. Partial overlap (yellow) of the supervillin (green) and Gαi (red) signals is apparent in the merged image. Scale bar = 2 µm.

Figure 8: Working model of the DRM-H membrane skeleton Hypothetical organization of the DRM-H membrane skeleton in neutrophil plasma membranes based on proteomic and microscopic evidence presented in this paper. DRM-H lipoprotein complexes are enriched in cholesterol and contain the integral membrane raft-associated proteins: stomatin, flotillin 1, and flotillin 2. These oligomeric proteins and tightly bound lipids are depicted here as a "lipid raft". Additional proteins typically associated with liquid-ordered domains are also present, including an extracellular GPI-anchored protein (MT6MMP), and intracellular dually acylated signaling proteins (Lyn, Gαi-2). Extracellular surface-bound IgM may be attached through a specific receptor. DRM-H rafts are characterized by a relatively high buoyant density in sucrose,

31


distribution, with a significant proportion co-purifying with membrane skeleton proteins. Numbers indicate sucrose

Nebl et al.


due to their association with membrane skeleton proteins (fodrin, F-actin, α-actinin, vimentin, myosin-IIA, myosinIG and supervillin). DRM-bound supervillin, myosin-IG, and myosin-IIA resist extraction with 0.1 M sodium carbonate, a treatment that removes all detectable actin and α-actinin, suggesting that the unextracted cytoskeletal proteins are more proximal to the DRM-H bilayer.


32

DRM Membrane Skeletons Nebl et al.


Figure 1

33



Figure 2

34



Figure 3

35

Nebl et al.

A


B Identity 1 α -fodrin 1 β -fodrin 2 myosin-IIA HC supervillin clathrin HC 1* α -fodrin myosin-IG HC3 α -actinin 4 α -actinin 1 4 IgM HC MT-6-MMP vimentin Lyn B flotillin 1 flotillin 2 β -actin 5 G(i) alpha 2

17

32.0

G(i) beta 2

18 19 20

31.7 25.0 17.9

6:8 8:13 3:3

21

19.8 17.5

stomatin 4 Ig variable LC bovine EST (G18.1b) 2 myosin-II RLC calmodulin3

Score PSD Accession # 1.5E+05 1 NP_003118 4.7E+05 2 NP_003119 5.2E+04 1 NP_002464 1.4E+02 1 T08878 1.3E+03 1 P49951 2.2E+03 1 NP_003118 6.2E+03 4 XP_059807 1.1E+04 1 NP_004915 5.8E+02 1 NP_001093 5.7E+05 2 AAB09544 2.2E+01 1 BAB20584 3.9E+01 1 P48616 2.2E+01 1 I53715 2.4E+01 1 NP_005794 7.5E+04 1 NP_004466 AAH08633 5.0E+04 1 6.9E+05 1 NP_002061 1.0E+03 1 NP_005264 8.3E+02 1 AAA58432 3.6E+03 nd AAA83145 AW425124 2.4E+01 2

1:6 1:6

3.6E+00 3.3E+00

1 1

NP_006462 nd AAB23129 nd

22 23

17.2 17.6

GAPR-1 bactenecin 1

3:6 7:11

3.3E+01 3.2E+02

1 1

AW599434 nd P22226 nd

MALDI-TOF† 10:11 13:18 11:14 6:9 8:8 16:20 13:21 10:13 7:10 10:13 4:10 7:11 8:16 4:18 11:18 10:10 11:14

5

7:10

†

Figure 4

36

WB Raft ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ nd ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔

Surface Cytoskeleton ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔

✔

✔

✔ nd nd nd

✔ ✔ ✔ ✔ ✔


# Mr(kDa) 1 284.3 2 274.6 3 226.5 4 200.6 5 191.5 6 150.0 7 115.0 8 104.2 9 103.0 10 80-90 11 62.6 12 56.0 13 53.7 47.3 14 42.6 15 41.0 16 37.0



Figure 5

37



Figure 6

38



Figure 7

39



Figure 8

40

Nebl et al.


SUPPLEMENTARY DATA FOR FIGURE 4 Band #

1

3

(est.) 245

235

210

Identity spectrin, alpha II (α-fodrin)

spectrin, beta II (β-fodrin)

myosin-IIA heavy chain (MYH 9)

m/z submitted 1144.70 1213.76 1213.76 1213.76 1369.90 1587.85 1587.85 1630.99 1707.94 1800.95 1863.98 2240.97 2331.01 2875.39 1036.44 1186.61 1241.63 1347.72 1381.58 1390.59 1413.52 1459.64 1459.64 1502.59 1580.71 1597.78 1614.71 1779.73 1862.75 1932.80 1977.78 2091.83 1283.83 975.51 1019.57 1068.66 1036.59 1155.75 1155.75 1155.75 1194.68 1523.69 1571.94 1633.93 1727.02 1869.98 1950.00 2049.03 2749.11

MH+ matched 1213.72 1213.69 1213.65 * 1369.79 1587.75 1587.76 1630.89 1707.86 1800.89 1863.96 2241.05 2331.07 2875.41 1036.49 1186.70 * 1241.70 * 1347.76 1381.63 1390.70

* Sequence(s) confirmed by MS/MS via MALDI-PSD

(R)AALLELWELR(R)

(R)LTTLELLEVR(R) (R)LILEVHQFSR(D)

1459.78 1459.70 1502.71 1614.88 1862.78 1977.95 2092.03 1284.12 975.45 1036.56 1155.59 1155.66 * 1155.66 1194.67 1571.85 1633.74 1726.94 1869.96 1949.99 2048.96 2749.32

41

(R)RGDLPFVVPR(R)


2

MW

Nebl et al.

4

5

205

180

150

bovine supervillin

bovine clathrin heavy chain

α-fodrin degradation product

872.45 971.48 1036.55 1036.55 1194.68 1571.82 1586.83 1755.89 1759.95 1846.83 1846.83 1110.75 1226.83 1296.75 1304.72 1453.83 1499.92 1942.89 1971.17 713.25 768.24 847.30 872.30 872.30 877.35 877.35 1036.41 1194.48 1213.58 1213.58 1213.58 1246.54 1246.54 1369.64 1393.55 1495.61 1556.62 1556.62 1586.66 1707.67 1800.75 1951.71 1951.71 1973.86 2240.86 2425.87 2425.87

971.51 1036.53 1036.57 1571.77 1586.73 1755.85 1846.87 * 1846.88 1110.66 1226.76 1296.67 1304.66 * 1453.92 1499.83 1942.91 1971.03

(K)YGSFEEAELSYPVLSR(V)

(R)NNLAGAEELFAR(K)

768.35 872.44 872.45 877.49 877.49 1194.62 1213.72 * 1213.69 1213.65 1246.64 1246.65 1369.79 1393.70 1495.74 1556.79 1556.80 1586.82 1707.86 1800.89 1951.86 1951.93 2241.05 2425.13 2425.26

42

(R)AALLELWELR(R)


6


Nebl et al.

7

9

115

105

105

myosin-IG heavy chain

non-muscle α-actinin 4

non-muscle α-actinin 1

1019.57 1063.49 1079.35 1103.61 1133.52 1172.63 1215.62 1294.63 1338.57 1380.72 1386.71 1391.69 1446.58 1511.78 1582.59 1648.79 1728.88 1744.86 2013.92 2132.95 2167.09 2167.09 1089.55 1215.65 1226.63 1252.62 1352.60 1386.80 1421.68 1429.7 1429.70 1481.74 1568.82 1675.8 1770.78 2008.00 1028.52 1081.57 1094.75 1187.72 1215.65 1386.80 1421.68 1429.70 1481.74 2008.00

1019.58 1103.66 1133.53 *

(K)GHTAAEASYARD(D)

1215.61 *

(R)DFLFQDFKR(L)

1338.65 1380.74 1391.69 1511.72 *

(R)HQVAYLGLLENVR(V)

1728.89 * 1744.88 2013.91

(R)HIMQYIAAVTNPSQR(A)

2167.06 2167.12 1215.67 * 1226.66 1252.62

(K)LASDLLEWIR(R)

1386.77 1421.70 1429.65 1429.76 1481.81 1568.85 1675.90 1028.55

1215.67 1386.77 * 1421.70 1429.76 1481.81 2008.96

43

(R)VGWEQLLTTIAR(T)


8


Nebl et al.

10

11

13

80-90

57

57

53

IgM heavy chain

MT-6-MMP (Leukolysin)

bovine vimentin

protein-tyrosine kinase, Lyn B

1036.51 1068.5 1194.55 1266.57 1412.65 1467.64 1502.73 1595.82 1633.73 1665.72 1783.85 1799.84 2233.87 848.39 1395.74 1551.80 1570.92 1888.90 1938.90 2220.10 2241.20 2378.20 2861.40 1125.59 1252.62 1311.67 1395.74 1435.64 1465.67 1509.82 1539.87 1570.92 1993.95 2219.02 1125.63 1220.69 1286.60 1395.76 1465.70 1510.90 1527.93 1571.80 1620.93 1741.00 1875.89 1926.90 1926.90 2121.96 2278.09 2403.20

1036.55 1194.63 * 1266.61 1412.68 1467.71 1595.91 1633.75 * 1783.97 1799.97 2234.16 848.42 * 1395.14

(R)FWTFPEVLR(D)

(K)GFAPADVFVQWLQR(G)

(K)GPWFWR(L)

1888.00 1938.02

1125.60 1252.59 1311.66

1509.80 1539.91 1570.89 *

(R)ISLPLPNFSSLNLR(E)

2218.95

1465.75 1510.83 1527.86 * 1571.76

1926.96 1926.91 2121.97 2278.07

44

(R)QLLAPGNSAGAFLIR(E)


12


Nebl et al.

14

16

17

45

42

37

32

flotillin 1 flotillin 2

actin (beta)

G(i) protein alpha 2 subunit

G(i) protein beta 2 subunit

1036.50 1098.61 1194.59 1252.68 1258.59 1269.68 1300.73 1378.75 1451.79 1468.83 1501.69 1514.78 1520.75 1633.79 1640.84 1657.77 2017.97 2325.19

flotillin 1 1368.73 1485.70 1514.85* 2018.03

795.36 923.45 976.35 1132.44 1198.57 1198.57 1354.50 1515.60 1790.65 1953.81 2342.84 909.40 921.48 1119.68 1380.82 1447.85 1463.82 1530.84 1534.86 1600.83 1686.92 1747.05 2063.06 2063.06 2077.07 2320.18 1194.74 1267.83 1336.72 1336.72 1577.84 1728.95 1771.03 1946.02 2089.00 2140.30 2240.20

795.47 923.56 976.44 1132.52 * 1198.70 1198.52 1354.62 1515.74 1790.89 1954.06 2343.16 909.42 921.48 1380.71 1530.72 1534.73 1600.73 1686.82 1746.90 * 2062.96 2063.02 2076.95 2320.08

flotillin 2 1036.52 1252.69 1269.71 1300.72 1378.78 * 1451.82 1468.83 1520.75 1640.89 1657.81 2325.20

1267.61 1336.61 1336.66 1577.72 1726.89 1770.89 * 1945.96 2140.19

45

(R)VFVLPCIQQIQR(I)

(K)NVVLQTLEGHLR(S)

(R)GYSFTTTAER(E)

(R)IAQSDYIPTQQDVLR(T)

(M)SELEQLRQEAEQLR(N)


15


Nebl et al.

18

19


31

25

stomatin (band 7.2b)

Ig lambda light chain (variable region)

18

bovine EST (G18.1b)

21

17

bovine EST(G18.1b) myosin II regulatory light chain calmodulin

22

23

16

12

bovine EST (GAPR1)

cyclic dodecapeptide precursor (bactenecin 1)

853.52 915.56 1195.71 *

(K)DVKLPVQLQR(A)

1601.87 1715.90 2028.11 nd 719.39 820.41

1678.97 1755.78 1970.91 1534.84 * 1958.09 * 2824.45

(R)ATFHPPKNPLSLGR(A) (R)SEPPLPPGGQELLLELLR(V)

1260.60 *

(R)IAQSDYIPTQQDVLR(T)

1754.87 *

(R)VFDKDGNGYISAAELR(H)

1395.69

2495.26 * 2518.16 1104.56 1121.59 1463.81 1690.77 1862.88 * 2147.04 2145.22 2303.14

46

(R)YFPAGNVVNQGFFEENVLPPKK(-)

(R)AVDQLNEQSSEPNIYR(L)


20

853.52 915.59 1195.81 1309.71 1562.93 1602.02 1716.06 2028.40 701.34 719.36 820.43 981.54 1025.54 1039.55 1235.67 1516.02 1679.05 1698.16 1756.05 1971.17 2014.42 1534.73 1958.90 2825.00 1213.52 1260.60 1534.85 1754.86 1958.10 2824.43 1395.81 1633.98 1663.98 1958.09 2495.21 2518.18 1104.58 1121.65 1463.83 1690.72 1862.77 2146.90 2146.90 2303.00

Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes Thomas Nebl, Kersi N. Pestonjamasp, John D. Leszyk, Jessica L. Crowley, Sang W. Oh and Elizabeth J. Luna J. Biol. Chem. published online August 28, 2002

Access the most updated version of this article at doi: 10.1074/jbc.M205386200 Alerts: • When this article is cited • When a correction for this article is posted Click here to choose from all of JBC's e-mail alerts Downloaded from http://www.jbc.org/ by guest on July 23, 2016

This article cites 0 references, 0 of which can be accessed free at http://www.jbc.org/content/early/2002/08/28/jbc.M205386200.citation.full.html#ref-list-1